会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • GENE EXPRESSION SIGNATURE FOR IL-6/STAT3 SIGNALING PATHWAY AND USE THEREOF
    • IL-6 / STAT3信号途径的基因表达及其用途
    • US20150232926A1
    • 2015-08-20
    • US14398532
    • 2013-05-03
    • Zhong WuMartin SchlumpbergerJohn DicarloVikram DevganYexun Wang
    • Zhong WuMartin SchlumpbergerJohn DicarloVikram DevganYexun Wang
    • C12Q1/68
    • C12Q1/6883C12N15/113C12N2310/14C12Q1/6886C12Q2600/158C12Q2600/16
    • The present invention relates to a set of biomarkers, microarrays that provide for detection thereof, an expression signature comprising 16 genes or a subset thereof, and the use thereof in determining the regulation status of IL-6/STAT3 signaling pathway in a cell sample or subject, as well as compositions for the detection thereof. The regulation status of IL-6/STAT3 signaling pathway in a cell sample or subject may be assayed based on the level of expression of one or more of these genes. The methods and compositions provided herein may be used to evaluate IL-6/STAT3 pathway regulation status in a sample; classify a cell sample as having a deregulated or regulated IL-6/STAT3 signaling pathway; determine whether an agent modulates the IL-6/STAT3 signaling pathway; predict the response of a subject to an agent that modulates the IL-6/STAT3 signaling pathway; assign treatment to a subject; and/or evaluate the pharmacodynamic effects of therapies designed to regulate IL-6/STAT3 pathway signaling. Expression of the biomarkers is preferably determined by RT-PCR using SYBR Green methods, and the expression data analyzed and compared to a control sample by use of the random forest method.
    • 本发明涉及提供其检测的一组生物标志物,微阵列,包含16个基因或其子集的表达标签,以及其用于确定细胞样品中IL-6 / STAT3信号传导途径的调节状态或 受试者以及用于检测的组合物。 可以基于这些基因中的一种或多种的表达水平来测定细胞样品或受试者中IL-6 / STAT3信号通路的调节状态。 本文提供的方法和组合物可用于评估样品中的IL-6 / STAT3通路调节状态; 将细胞样品分类为具有去调节或调节的IL-6 / STAT3信号传导途径; 确定试剂是否调节IL-6 / STAT3信号通路; 预测受试者对调节IL-6 / STAT3信号通路的药剂的反应; 为受试者分配治疗; 和/或评估旨在调节IL-6 / STAT3通路信号传导的疗法的药效学作用。 优选通过使用SYBR Green方法的RT-PCR来确定生物标志物的表达,并且通过使用随机森林法分析表达数据并与对照样品进行比较。
    • 6. 发明申请
    • METHOD FOR ISOLATING A TARGET NUCLEIC ACID INCLUDING SMALL TARGET NUCLEIC ACIDS WITH HIGH YIELD
    • 用于分离靶向核酸的方法,包括具有高YIELD的小目标核酸
    • US20130164825A1
    • 2013-06-27
    • US13820228
    • 2011-09-02
    • Vera HolländerGabriele ChristoffelMartin Schlumpberger
    • Vera HolländerGabriele ChristoffelMartin Schlumpberger
    • C07H1/08
    • C12N15/1006C12N15/1017
    • The present invention pertains to a method for isolating a target nucleic acid including small target nucleic acids from a sample, said method comprising at least the following steps a) binding at least a portion of the target nucleic acid including small target nucleic acids to a nucleic acid binding solid phase comprised in a column by passing the sample through said column, b) performing an enzymatic and/or chemical treatment on the nucleic acid binding solid phase while the target nucleic acid is bound to said solid phase, c) collecting at least a portion of the small target nucleic acids released from the solid phase during said treatment of step b) as flow-through, d) contacting said flow-through which comprises small target nucleic acids mixed with a recovery solution with a nucleic acid binding solid phase for binding the contained small target nucleic acids to said nucleic acid binding solid phase, e) optionally performing an elution. The present invention results in a considerable increase in the yield of small target nucleic acids in the isolated target nucleic acid because it allows to efficiently capture and recover small target nucleic acids.
    • 本发明涉及从样品中分离包含小靶核酸的靶核酸的方法,所述方法至少包括以下步骤:a)将包含小靶核酸的靶核酸的至少一部分结合至核酸 通过使样品通过所述柱而包含在柱中的酸结合固相,b)对核酸结合固相进行酶和/或化学处理,同时靶核酸与所述固相结合,c)至少收集 在步骤b)的所述处理期间从固相中释放的一部分小目标核酸作为流通,d)使所述流通接触,所述流过包含与回收溶液混合的小目标核酸与核酸结合固相 用于将所含的小靶核酸与所述核酸结合固相结合,e)任选地进行洗脱。 本发明导致分离的靶核酸中小靶核酸的产量显着增加,因为其允许有效捕获和回收小靶核酸。